Despite the advance in medical imaging, it is important to validate new imaging biomarkers for a particular disease against histopathology, which is considered the ground truth. Here we propose a methodology for the quantitative validation of MRI biomarkers by the co-registration of histological probability maps with MR images. Using a mouse model of infiltrative brain tumours, we show this approach is far more robust than those currently applied.
This abstract and the presentation materials are available to members only; a login is required.